Sentences with phrase «zika vaccine»
On Monday, the National Institutes of Health (NIH) announced the launch of the first of five clinical trials in humans to test the safety and effectiveness of a Zika vaccine.
http://www.health.com/
Meanwhile, the Obama administration said last week that it will transfer $ 81 million from existing federal health programs so there's enough money to continue trials of a Zika vaccine.
The study, published in the August issue of the journal Science Communication, examines what happened in August 2016 after the launch of the first human trial of a Zika vaccine.
They are among 34 groups in Florida to receive a piece of $ 25 million in state funds that Gov. Rick Scott OK's last year for Zika vaccine development, testing methods and understanding the long - term impact of the virus.
More than a dozen experimental clinical therapies and vaccines have been developed from research from the Weiner laboratory, including the first Zika vaccine in clinical trials, as well as a novel immunotherapy for HPV - associated cancer and precancer.
The Walter Reed Army Institute of Research (WRAIR) announces a Cooperative Research and Development Agreement for the development of a Zika vaccine candidate with Sanofi Pasteur, the vaccines division of Sanofi.
Not surprisingly, there has been a race to create a Zika vaccine — a drug to protect still - unexposed people from this mosquito - borne virus.
Recently at Wistar, Muthumani was one of the creators of a Zika vaccine that was the first to enter clinical trial.
UNC School of Medicine's Aravinda de Silva, PhD, who is currently working on NIH - funded Zika vaccine development and other Zika research, is a co-author.
De Silva and Metz were recently named to a global research consortium to tackle Zika, and they're using the same nanoparticle vaccine platform as they work to develop a Zika vaccine.
It would be interesting to assess whether the antibodies induced by these Zika vaccine types increase infection by dengue viruses.
This new mouse model could be very useful in allowing an initial comparative assessment of the likely potential value of the large number of Zika vaccine candidates being developed around the world.
«At least that's how we're hoping the Zika vaccine will work.»
«This is an encouraging first step in Zika vaccine design and pre-clinical testing.
«But, overall, this report illustrates well the current rapid pace of Zika vaccine development and one US company (Inovio) reported recently plans to start a trial of their DNA vaccine technology for Zika very soon.»
ZIKAVAX is a new EVI project funded by the European Commission that aims to develop a measles based Zika vaccine.
Zika and dengue are in the same family of viruses, and NIH officials have said they hope to cut the timeline for having a Zika vaccine by building on their work on dengue.
[NIH officials accelerate timeline for human trials of Zika vaccine, saying they will now begin in the summer]
The promising results bode well for efforts to develop a Zika vaccine.
Our investigational Zika vaccine, mRNA - 1325, is being developed to deliver mRNA encoding for viral antigenic proteins associated with the Zika virus.
A safe and effective Zika vaccine that prevents infection in those at risk is a global public health priority,» said Maj. Leyi Lin, principal investigator of the study.
PHILADELPHIA --(April 19, 2018)-- The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their ground - breaking phase 1 DNA - based Zika vaccine research — the first trial of a Zika vaccine in humans, which proved safe and effective.
This paper showcased research results from the new DNA - based Zika vaccine that is based on synthetic DNA and gives instructions to the body's immune system to produce antibodies to attack Zika antigens (i.e. bacteria, viruses, and other foreign substances that trigger immune responses from the body.)
«The Army was able to move so quickly in developing, manufacturing and testing a Zika vaccine because of its extensive experience with this vaccine platform and long standing investments in the understanding and mitigation of flaviviruses, like yellow fever, dating back to the founding of WRAIR,» said Dr. Kayvon Modjarrad, Zika program co-lead and associate director for Emerging Infectious Disease Threats at WRAIR's MHRP.
People's willingness to use a Zika vaccine when it's available will be influenced by how they weigh the risks associated with the disease and the vaccine, but also by their misconceptions about other vaccines, a new study has found.
It will be important to test all this thoroughly before releasing any Zika vaccine, since regions of the world with Zika also have dengue.
The more likely someone is to believe in the false association between the use of the MMR vaccine and autism, the less likely that person is to use a Zika vaccine;
«False beliefs about MMR vaccine found to influence acceptance of Zika vaccine: Study finds spillover effect from misbeliefs about MMR vaccine and autism.»
Just one dose of a newly developed Zika vaccine gives mice complete immunity to the disease.
Once the Zika vaccine exists, health communicators will have to cope with «vaccine hesitancy» and anti-vaccine communications.
Nelson Michael of the Walter Reed Army Institute of Research in Silver Spring, Maryland, says that the trial Zika vaccine will be tested on mice and monkeys that already have antibodies to dengue, to see if that interferes with the vaccine.
In a review paper published in the journal Immunity, a group of leading vaccine scientists — including Dan H. Barouch, MD, PhD, of Beth Israel Deaconess Medical Center (BIDMC)-- outline advances in the hunt for a Zika vaccine and the challenges that still lie ahead.
Safety considerations are especially critical, given that the target population for a Zika vaccine would likely include men and women of childbearing age.
«The rapid advancement of Zika vaccine candidates into clinical trials reflects the uniquely focused and effective collaboration among scientists in the field to address this important global problem,» said Barouch.
Unlike other candidates, a new potential Zika vaccine is so effective that one shot gives enough protection — a key advance, given the virus is here to stay
«The study indicates that prior flavivirus immunity is unlikely to impact the safety of a Zika vaccine candidate.
«Taken together, our findings provide substantial optimism that the development of a safe and effective Zika vaccine for humans will likely be feasible,» they write.
The Walter Reed Army Institute of Research (WRAIR) and collaborators at the Beth Israel Deaconess Medical Center and Harvard Medical School have completed a promising preclinical study of two Zika vaccine candidates that suggests that an effective human vaccine will be achievable.
Science's picks for Areas to watch in 2017 are human embryo research, Zika vaccine trials, the search for Planet Nine, and the impacts on research of the U.S. election and «Brexit» vote.
«New mouse model to aid testing of Zika vaccine, therapeutics: Model mimics aspects of infection in people.»
«New Zika vaccine candidate protects mice and monkeys with a single dose: Results from study highlight the promise of mRNA - based vaccines and therapies.»
Our Zika vaccine showed promising safety profile in mice when compared with clinically approved live - attenuated vaccines, such as the yellow fever vaccine,» Shi said.
The first live - attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from The University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil.
«These Phase 1 ZPIV studies are an important step towards bringing an effective Zika vaccine to fruition.
There is currently no Zika vaccine, so preventing mosquito bites and using condoms — the virus can also be spread by human sexual contact — remain the predominant ways to combat its spread.
At Penn, two different Zika vaccine candidates are in various stages of development.
A phase I clinical trial for a Zika vaccine which began in August 2016 in partnership with the Wistar Institute and Inovio / GeneOne Pharmaceuticals aims to discover the safety and effectiveness of a DNA vaccine for Zika.
Esty said lawmakers were discussing setting up a permanent emergency fund that would available for projects like working on a Zika vaccine, though she was optimistic that Obama's funding request would be approved without being tied to a larger, partisan battle over the federal budget.
Head of the firm, Biotech International Limited, Dr. Krishna Ella, said at a news conference on Wednesday that it had already filed for a patent for the Zika vaccine.
He's optimistic that a Zika vaccine would come closer to providing blanket protection.